Actively Recruiting
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Led by Mayo Clinic · Updated on 2026-02-03
550
Participants Needed
1
Research Sites
430 weeks
Total Duration
On this page
Sponsors
M
Mayo Clinic
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test the effectiveness of a new investigational breast ultrasound method to detect an abnormality in the breast, and assess response to breast cancer treatment.
CONDITIONS
Official Title
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient volunteers aged 18 years or older with suspicious breast masses scheduled for biopsy or at least two weeks after breast biopsy
- Patient volunteers aged 18 years or older with biopsy-proven breast cancer undergoing neoadjuvant chemotherapy and/or endocrine therapy who had baseline MRI and/or ultrasound
You will not qualify if you...
- Patients with breast implants or any condition that prevents proper use of ultrasound
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here